By Kate Rawson
There’s a funny thing happening at the Food & Drug Administration these days: more drugs are getting approved by the...
Woodcock to the Rescue: Is CDER Approving More Products?
The financial community believes in Janet Woodcock: some analysts are predicting an improving climate for drug approvals based on her return to FDA's Center for Drug Evaluation & Research. Woodcock says standards aren't changing-but she does seem to relish making the tough decisions that make some approvals possible.